Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

40.04 -0.35 (-0.87%)

Delayed Quote Updated: 2:32 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited Ordinary Shares

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

35 36 Next >

Teva’s 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained long-term effectiveness in reducing frequency, duration and severity of attacks in patients with chronic and episodic migraine

June 30, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Geopolitical Risks Prevail ↗

June 27, 2023

A discussion about current geopolitical risks and their impact on commodity and stock markets.

Via Talk Markets

ADHD Medication Shortage Worsens, Vyvanse Supply Dwindles Amid Adderall Scarcity ↗

June 21, 2023

The supply of an alternative to Adderall, Vyvanse (lisdexamfetamine), a commonly used medication for Attention-deficit/hyperactivity disorder (ADHD), is dwindling, further limiting options for patients...

Via Benzinga

3 Bargain Stocks to Buy on the Dip ↗

June 17, 2023

These stocks should be poised to rebound.

Via The Motley Fool

Teva to Present Data at the 2023 American Headache Society Annual Scientific Meeting Demonstrating AJOVY® (fremanezumab-vfrm) Injection Significantly Reduced Migraine and Depression Symptoms in Patients

June 15, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Why Teva Pharmaceutical Stock Is Jumping Today ↗

May 18, 2023

Investors are reacting positively to Teva's new growth strategy.

Via The Motley Fool

Teva Reaches Agreement With Kentucky to Settle the State’s Price Fixing Claims

June 12, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape ↗

June 12, 2023

The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March. Methotrexate is an injected medication utilized to treat...

Via Benzinga

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

June 12, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

June 12, 2023

From Alvotech

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 09, 2023

Via Benzinga

Is AbbVie or Amgen the Better Bargain Buy Right Now? ↗

June 08, 2023

These elite drugmakers are both working through a number of headwinds.

Via The Motley Fool

Teva Concludes Nationwide Opioids Settlement Agreement

June 08, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management

June 06, 2023

From Phil Inc.

Via Business Wire

Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy? ↗

June 05, 2023

It's unclear whether the pivot will be enough to halt its recent decline.

Via The Motley Fool

Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration Kit at Psych Congress Elevate 2023

June 02, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023 ↗

May 25, 2023

Via Benzinga

Teva to Present Data Demonstrating UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolonged Time to Impending Relapse for Adults with Schizophrenia at the American Psychiatric Association’s 2023 Annual Meeting

May 20, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023 ↗

May 18, 2023

Via Benzinga

Why Is Alimera Sciences (ALIM) Stock Up 21% Today? ↗

May 18, 2023

Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (EYPT).

Via InvestorPlace

Why Is Teva Pharmaceuticals (TEVA) Stock Up Today? ↗

May 18, 2023

Teva Pharmaceuticals (TEVA) stock is climbing higher on Thursday after the pharmaceutical company announced a new growth strategy.

Via InvestorPlace

Netflix, Synopsys, Madison Square Garden Entertainment And Other Big Stocks Moving Higher On Thursday ↗

May 18, 2023

U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session. Urstadt Biddle Properties Inc. (NYSE: UBP) shares surged...

Via Benzinga

Teva Launches New “Pivot to Growth” Strategy

May 18, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories ↗

May 17, 2023

Benzinga

Via Benzinga

One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps ↗

May 17, 2023

AstraZeneca Plc (NASDAQ: AZN) has decided to leave a U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), making it the third company to leave the group in the last...

Via Benzinga

A Bitter Pill to Swallow: Teva's $235M Challenge to GSK Dismissed by Supreme Court ↗

May 15, 2023

The U.S.

Via Benzinga

AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, New Once-Daily Formulation of AUSTEDO®, Now Available in the U.S.

May 15, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 12, 2023

Via Benzinga

Teva Pharmaceutical Industries (TEVA) Q1 2023 Earnings Call Transcript ↗

May 10, 2023

TEVA earnings call for the period ending March 31, 2023.

Via The Motley Fool

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.